Showing items 1 - 2 of 2

Your selections:

Health technology assessment, international reference pricing, and budget control tools from China's perspective: what are the current developments and future considerations?

- Koh, Liling, Glaetzer, Christoph, Chuen Li, Shu, Zhang, Meng

Good research practices for measuring drug costs in cost-effectiveness analyses: an international perspective: the ISPOR Drug Cost Task Force Report-Part VI

- Shi, Lizheng, Hodges, Meredith, Drummond, Michael, Ahn, Jeonghoon, Li, Shu Chuen, Hu, Shanlian, Augustovski, Federico, Hay, Joel W., Smeeding, Jim

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit